GNAO1 as a Novel Predictive Biomarker for Late Relapse in Hepatocellular Carcinoma

Figure 4

Construction of a prognostic model for HCC relapse assessment. (a) ROC analysis for GNAO1 expression and clinicopathologic parameters; (b) prognostic nomogram for HCC patients; and (c) calibration curves for the nomogram at 3 years.

(a)

(b)

(c)